Symptoms
Common signs and symptoms of Kaposi Sarcoma (HHV-8) include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Kaposi Sarcoma (HHV-8).
Kaposi sarcoma develops when cells lining blood and lymphatic vessels become infected with human herpesvirus 8 (HHV-8) and begin growing abnormally.
Kaposi sarcoma develops when cells lining blood and lymphatic vessels become infected with human herpesvirus 8 (HHV-8) and begin growing abnormally. This virus, also called Kaposi sarcoma-associated herpesvirus, is the primary cause of all forms of Kaposi sarcoma. However, simply having HHV-8 infection doesn't automatically lead to cancer development. The virus can remain dormant in the body for years without causing problems.
The transformation from viral infection to cancer typically requires a weakened immune system.
The transformation from viral infection to cancer typically requires a weakened immune system. When immune function declines, the virus can reactivate and begin producing proteins that interfere with normal cell growth controls. These viral proteins essentially hijack the infected cells, causing them to multiply rapidly and form the characteristic lesions of Kaposi sarcoma. The virus also promotes the formation of new blood vessels, which feeds tumor growth.
Several factors can trigger this progression from dormant infection to active cancer.
Several factors can trigger this progression from dormant infection to active cancer. HIV infection remains the most significant trigger, as it progressively weakens the immune system's ability to control HHV-8. Other conditions that suppress immune function, such as organ transplant medications or certain autoimmune diseases, can also allow the virus to reactivate. Genetic factors may influence how susceptible someone is to both HHV-8 infection and subsequent cancer development.
Risk Factors
- HIV infection or AIDS
- Immunosuppressive medications after organ transplant
- Male gender, especially men who have sex with men
- Mediterranean, Eastern European, or Middle Eastern ancestry
- Living in areas where HHV-8 infection is common
- Advanced age, particularly over 50
- Autoimmune diseases requiring immunosuppressive treatment
- Chronic corticosteroid use
- Previous history of other cancers
- Poor overall health status
Diagnosis
How healthcare professionals diagnose Kaposi Sarcoma (HHV-8):
- 1
Diagnosing Kaposi sarcoma typically begins when a doctor notices the characteristic skin lesions during a physical examination.
Diagnosing Kaposi sarcoma typically begins when a doctor notices the characteristic skin lesions during a physical examination. These distinctive purple, red, or brown patches often have a specific appearance that experienced physicians can recognize, but definitive diagnosis requires tissue analysis. The doctor will examine the entire body, including inside the mouth, to identify all visible lesions and assess the extent of skin involvement.
- 2
A skin biopsy is the gold standard for confirming Kaposi sarcoma diagnosis.
A skin biopsy is the gold standard for confirming Kaposi sarcoma diagnosis. During this procedure, the doctor removes a small sample of abnormal tissue, usually under local anesthesia. The pathologist examines this tissue under a microscope and performs special stains to identify the characteristic spindle-shaped cells and blood vessel changes typical of Kaposi sarcoma. Testing for HHV-8 viral proteins in the tissue sample can provide additional confirmation.
- 3
Once the diagnosis is confirmed, doctors perform staging tests to determine how extensively the cancer has spread.
Once the diagnosis is confirmed, doctors perform staging tests to determine how extensively the cancer has spread. These may include: - CT scans of the chest, abdomen, and pelvis - Endoscopic examination of the digestive tract - Bronchoscopy if lung involvement is suspected - Blood tests to assess immune function and overall health - HIV testing if status is unknown The staging process helps doctors classify the disease as limited to skin only or involving internal organs, which significantly influences treatment decisions.
Complications
- The complications of Kaposi sarcoma depend largely on where the tumors develop and how extensively they spread.
- Skin lesions, while often the most visible aspect of the disease, typically cause more cosmetic and psychological distress than physical complications.
- However, lesions on the feet and legs can become quite large, causing significant swelling, pain, and difficulty walking.
- Secondary bacterial infections can develop in these areas, particularly when lesions break down or ulcerate.
- Internal organ involvement creates more serious complications.
- Pulmonary Kaposi sarcoma can cause progressive shortness of breath, chronic cough, and potentially life-threatening respiratory failure.
- Gastrointestinal involvement may lead to bleeding, obstruction, or malabsorption of nutrients.
- Lymph node involvement can cause severe swelling of arms or legs, creating functional impairment and increased infection risk.
- These complications often require aggressive treatment and can significantly impact quality of life and survival.
- The psychological and social impact of Kaposi sarcoma shouldn't be underestimated.
- The visible nature of skin lesions can cause significant distress, social isolation, and depression.
- Many patients struggle with the stigma associated with the disease, particularly given its association with HIV/AIDS.
- Access to counseling, support groups, and resources for covering lesions with makeup or clothing can be essential components of comprehensive care.
Prevention
- Attend all scheduled medical appointments
- Take HIV medications exactly as prescribed
- Maintain overall health through good nutrition and exercise
- Avoid excessive alcohol and drug use
- Get vaccinated against preventable infections
Treatment for Kaposi sarcoma varies dramatically based on the patient's immune status, the extent of disease, and which of the four main types is present.
Treatment for Kaposi sarcoma varies dramatically based on the patient's immune status, the extent of disease, and which of the four main types is present. For people with HIV-associated Kaposi sarcoma, the cornerstone of treatment is effective antiretroviral therapy to restore immune function. When the immune system recovers, it can often control the HHV-8 virus naturally, leading to improvement or even resolution of Kaposi sarcoma lesions without additional cancer treatment.
For localized skin lesions, doctors have several effective options: - Radiation therapy for small numbers of lesions - Cryotherapy (freezing treatment) for individual lesions - Intralesional chemotherapy injected directly into tumors - Topical medications like imiquimod or retinoids - Surgical excision for accessible lesions These local treatments work well for limited disease but aren't practical when many lesions are present.
For localized skin lesions, doctors have several effective options: - Radiation therapy for small numbers of lesions - Cryotherapy (freezing treatment) for individual lesions - Intralesional chemotherapy injected directly into tumors - Topical medications like imiquimod or retinoids - Surgical excision for accessible lesions These local treatments work well for limited disease but aren't practical when many lesions are present.
Systemic treatment becomes necessary when Kaposi sarcoma is widespread or involves internal organs.
Systemic treatment becomes necessary when Kaposi sarcoma is widespread or involves internal organs. Chemotherapy options include liposomal doxorubicin, paclitaxel, or combination regimens like ABV (adriamycin, bleomycin, vincristine). These medications are generally well-tolerated and can achieve significant tumor shrinkage. Newer targeted therapies and immunotherapy approaches are showing promise in clinical trials, offering hope for even better outcomes in the future.
For transplant-associated Kaposi sarcoma, reducing immunosuppressive medications is often the first step, though this must be balanced against the risk of organ rejection.
For transplant-associated Kaposi sarcoma, reducing immunosuppressive medications is often the first step, though this must be balanced against the risk of organ rejection. Some patients may benefit from switching to different immunosuppressive drugs that are less likely to promote Kaposi sarcoma development. Close coordination between oncologists and transplant specialists is essential for optimal management.
Living With Kaposi Sarcoma (HHV-8)
Living with Kaposi sarcoma requires ongoing medical care and attention to both physical and emotional well-being. Regular follow-up appointments are essential for monitoring disease progression, adjusting treatments, and catching any complications early. Patients should perform monthly self-examinations of their skin, looking for new lesions or changes in existing ones, and report any concerns to their healthcare team promptly.
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Mar 20, 2026v1.0.0
- Published by DiseaseDirectory